Sign in
8-K

Current Report

Acrivon Therapeutics, Inc. Filed Acc 0000950170-24-075760

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading acrv-20240620.htm…